Clinical Trial Update: Treatment Resistant Epilepsy and N-Acetyl Cysteine [NA]

View source ↗

Summary

A clinical trial investigating N-Acetyl Cysteine for treatment-resistant epilepsy in autism with irritability has been withdrawn; no results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Epilepsy

Drugs mentioned

• N-Acetyl-Cysteine (N-acetylcysteine)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Autistic Disorder, Seizures | NA | Status: WITHDRAWN